Skip to search boxSkip to navigationSkip to main content

Renoprotective role of the vitamin D receptor in diabetic nephropathy

  • Z. Zhang
    ,
  • L. Sun
    ,
  • ,
  • G. Ning
    ,
  • A. W. Minto
    ,
  • J. Kong
*Corresponding author for this work
  • The University of Chicago
    ,
  • Pennsylvania State University
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

1,25-Dihydroxyvitamin D3 negatively regulates the renin-angiotensin system (RAS), which plays a critical role in the development of diabetic nephropathy. We tested if mice lacking the vitamin D receptor (VDR) are more susceptible to hyperglycemia-induced renal injury. Diabetic VDR knockout mice developed more severe albuminuria and glomerulosclerosis due to increased glomerular basement membrane thickening and podocyte effacement. More fibronectin (FN) and less nephrin were expressed in the VDR knockout mice compared to diabetic wild-type mice. In receptor knockout mice, increased renin, angiotensinogen, transforming growth factor-β (TGF-β), and connective tissue growth factor accompanied the more severe renal injury. 1,25-Dihydroxyvitmain D3 inhibited high glucose (HG)-induced FN production in cultured mesangial cells and increased nephrin expression in cultured podocytes. 1,25-Dihydroxyvitmain D3 also suppressed HG-induced activation of the RAS and TGF-β in mesangial and juxtaglomerular cells. Our study suggests that receptor-mediated vitamin D actions are renoprotective in diabetic nephropathy.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 163-171 (9 pages)

Journal (Volume, Issue Number)

Kidney International (Volume 73, Issue 2)

Publication milestones

  • Published - 01/10/2008

Publication status

Published - 01/10/2008

ISSN

0085-2538

Publication IDs

  • Scopus: 37549046405
  • PubMed: 17928826

Publication metrics

Metrics

SciVal
FWCI
8.48
SciVal
Author count
8
SciVal
citations
242
SciVal
Paper percentile
99
SciVal
Top percentile
1
Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
106
Citation count
300
Mentions
1

Funding Details

This work was supported by NIH Grant no. DK073183 and American Diabetes Association Grant no. 7–05-RA-80 (to YCL).
FundersFunding number
NIH
-
NIDDK
R21DK073183